AtriCure to Announce Third Quarter 2024 Financial Results
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation, left atrial appendage management, and post-operative pain management, has announced it will release its third quarter 2024 financial results on Tuesday, October 29, 2024. The company will host an audio webcast at 4:30 p.m. Eastern Time on the same day to discuss the results.
Interested parties can register for the conference call online using the provided link. Registration is recommended more than 15 minutes before the call starts. Both live and replay versions of the audio webcast will be available on AtriCure's investor relations website.
AtriCure, Inc. (Nasdaq: ATRC), un innovatore leader nei trattamenti chirurgici per la fibrillazione atriale, nella gestione dell'appendice atriale sinistra e nella gestione del dolore post-operatorio, ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre 2024 martedì 29 ottobre 2024. L'azienda ospiterà un audio webcast alle 16:30 ora orientale lo stesso giorno per discutere i risultati.
Le parti interessate possono registrarsi per la conferenza telefonica online utilizzando il link fornito. Si consiglia di registrarsi con oltre 15 minuti di anticipo rispetto all'inizio della chiamata. Sia la versione in diretta che quella registrata dell'audio webcast saranno disponibili sul sito web delle relazioni con gli investitori di AtriCure.
AtriCure, Inc. (Nasdaq: ATRC), un innovador líder en tratamientos quirúrgicos para la fibrilación auricular, la gestión de la appendice auricular izquierda y la gestión del dolor postoperatorio, ha anunciado que lanzará sus resultados financieros del tercer trimestre de 2024 el martes 29 de octubre de 2024. La compañía llevará a cabo un audio webcast a las 4:30 p.m. hora del este el mismo día para discutir los resultados.
Las partes interesadas pueden registrarse para la llamada en conferencia en línea utilizando el enlace proporcionado. Se recomienda registrarse con más de 15 minutos de antelación al inicio de la llamada. Tanto la versión en vivo como la grabada del audio webcast estarán disponibles en el sitio web de relaciones con inversores de AtriCure.
AtriCure, Inc. (Nasdaq: ATRC), 심방 세동 수술 치료, 좌심방 부속기 관리 및 수술 후 통증 관리 분야의 선도적인 혁신 기업이 2024년 3분기 재무 결과를 2024년 10월 29일 화요일에 발표할 것이라고 발표했습니다. 회사는 같은 날 동부 표준시 오후 4시 30분에 재무 결과에 대해 논의하는 오디오 웨비나를 진행할 예정입니다.
관심 있는 당사자는 제공된 링크를 사용하여 온라인에서 컨퍼런스 콜에 등록할 수 있습니다. 통화 시작 15분 이상 전에 등록하는 것이 권장됩니다. AtriCure의 투자자 관계 웹사이트에서는 오디오 웨비나의 실시간 및 재생 버전을 모두 이용할 수 있습니다.
AtriCure, Inc. (Nasdaq: ATRC), un innovateur de premier plan dans les traitements chirurgicaux de la fibrillation auriculaire, la gestion de l’appendice auriculaire gauche et la gestion de la douleur post-opératoire, a annoncé qu'il publiera ses résultats financiers du troisième trimestre 2024 le mardi 29 octobre 2024. L'entreprise organisera un webcast audio à 16h30 heure de l'Est le même jour pour discuter des résultats.
Les parties intéressées peuvent s'inscrire à la conférence téléphonique en ligne en utilisant le lien fourni. Il est recommandé de s'inscrire plus de 15 minutes avant le début de l’appel. Les versions en direct et en différé du webcast audio seront disponibles sur le site Web des relations avec les investisseurs d'AtriCure.
AtriCure, Inc. (Nasdaq: ATRC), ein führender Innovator im Bereich chirurgische Behandlungen von Vorhofflimmern, Management des linken Vorhofohres und postoperativen Schmerzmanagements, hat angekündigt, dass es am Dienstag, den 29. Oktober 2024, seine Finanzergebnisse für das dritte Quartal 2024 veröffentlichen wird. Das Unternehmen wird am selben Tag um 16:30 Uhr Eastern Time ein Audiowebcast veranstalten, um die Ergebnisse zu diskutieren.
Interessierte Parteien können sich online über den bereitgestellten Link für die Telefonkonferenz registrieren. Es wird empfohlen, sich mehr als 15 Minuten vor Beginn des Anrufs zu registrieren. Sowohl die Live- als auch die Replay-Version des Audiowebcasts werden auf der Website der Investorenbeziehungen von AtriCure verfügbar sein.
- None.
- None.
AtriCure will host an audio webcast at 4:30 p.m. Eastern Time on Tuesday, October 29, 2024, to discuss its third quarter 2024 financial results. Those interested in listening to the conference call should register online using this link. Participants are encouraged to register more than 15 minutes before the start of the call. A live and replay version of the audio webcast will be available at https://ir.atricure.com/events-and-presentations/events.
About AtriCure
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists, cardiothoracic and thoracic surgeons around the globe use AtriCure technologies for the treatment of Afib, reduction of Afib related complications and post-operative pain management. AtriCure’s Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure’s cryoICE cryoSPHERE® probes are cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on X (formerly Twitter) @AtriCure.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241008614077/en/
Angie Wirick
AtriCure, Inc.
Chief Financial Officer
(513) 755-5334
awirick@atricure.com
Marissa Bych
Gilmartin Group
Investor Relations
marissa@gilmartinir.com
Source: AtriCure, Inc
FAQ
When will AtriCure (ATRC) release its Q3 2024 financial results?
What time is AtriCure's (ATRC) Q3 2024 earnings call scheduled for?
How can I access AtriCure's (ATRC) Q3 2024 earnings call?
What products does AtriCure (ATRC) specialize in?
